Intracranial Gliomas Part II - Adjuvant Therapy

Editor(s): Chernov, M.F. (Tokyo)
Muragaki, Y. (Tokyo)
Kesari, S. (Santa Monica, CA)
McCutcheon, I.E. (Houston, TX)
 

Physical and Psychological Rehabilitation of Patients with Intracranial Glioma

Andrejeva J.a · Volkova O.V.b

Author affiliations

aDepartment of Rehabilitation, Faculty of Health Sciences, Klaipeda University, Klaipeda, Lithuania; and bDepartment of Clinical Psychology and Psychotherapy, Krasnoyarsk State Medical University Named after Professor V.F. Voyno-Yasenetsky, Krasnoyarsk, Russia

Related Articles for ""
Chernov MF, Muragaki Y, Kesari S, McCutcheon IE (eds): Intracranial Gliomas. Part II - Adjuvant Therapy. Prog Neurol Surg. Basel, Karger, 2018, vol 31, pp 210-228
https://doi.org/10.1159/000467381

Log in to MyKarger to check if you already have access to this content.


Sign up to MyKarger

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00

Select

Complete book

  • Immediate access to all parts of this book
  • Cover-to-cover formats may be available
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restriction for personal use
read more

Pricing depends on hard-cover price

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of  

Published online: January 25, 2018
Cover Date: 2018

Number of Print Pages: 19
Number of Figures: 0
Number of Tables: 0

ISBN: 978-3-318-06058-4 (Print)
eISBN: 978-3-318-06059-1 (Online)

Abstract

Patients with brain tumor frequently experience a combination of physical, cognitive, and communication deficits. These may cause severe psycho-emotional stress altering biological and mental conditions and complicating the course of the primary disease, and thus necessiate physical and psychological rehabilitation. While existing data on the effectiveness of such treatment in patients with intracranial glioma are limited and inconsistent, it is possible to suggest that systematic and multidisciplinary rehabilitation plays a very important therapeutic role and leads to improvements in functional independence, mental and emotional state, and quality of life.

© 2018 S. Karger AG, Basel



Related Articles:

References

  1. Cheville A: Rehabilitation of patients with advanced cancer. Cancer 2001;92(4 suppl):1039-1048.
  2. Bell KR, O'Dell MW, Barr K, Yablon SA: Rehabilitation of the patient with brain tumor. Arch Phys Med Rehabil 1998;79(3 suppl 1):S37-S46.
  3. Piil K, Juhler M, Jakobsen J, Jarden M: Controlled rehabilitative and supportive care intervention trials in patients with high-grade gliomas and their caregivers: a systematic review. BMJ Support Palliat Care 2016;6:27-34.
  4. Wen PY, Kesari S: Malignant gliomas in adults. N Engl J Med 2008;359:492-507.
  5. Nussbaum ES, Djalilian HR, Cho KH, Hall WA: Brain metastases. Histology, multiplicity, surgery, and survival. Cancer 1996;78:1781-1788.
  6. Chaichana KL, McGirt MJ, Laterra J, Olivi A, Quiñones-Hinojosa A: Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas. J Neurosurg 2010;112:10-17.
  7. Russell B, Collins A, Dally M, Dowling A, Gold M, Murphy M, Philip J: Living longer with adult high-grade glioma: setting a research agenda for patients and their caregivers. J Neurooncol 2014;120:1-10.
  8. van Loon EM, Heijenbrok-Kal MH, van Loon WS, van den Bent MJ, Vincent AJ, de Koning I, Ribbers GM: Assessment methods and prevalence of cognitive dysfunction in patients with low-grade glioma: a systematic review. J Rehabil Med 2015;47:481-488.
  9. Levinson SF: Rehabilitation of the patient with cancer or human immunodeficiency virus; in DeLisa JA (ed): Rehabilitation Medicine: Principles and Practice, ed 2. Philadelphia, Lippincott, 1993, pp 916-933.
  10. Wen PY, Fine HA, Black PM, Shrieve DC, Alexander E 3rd, Loeffler JS: High-grade astrocytomas. Neurol Clin 1995;13:875-900.
  11. Gordon WA, Zafonte R, Cicerone K, Cantor J, Brown M, Lombard L, Goldsmith R, Chandna T: Traumatic brain injury rehabilitation: state of the science. Am J Phys Med Rehabil 2006;85:343-382.
  12. Maschio M, Dinapoli L, Fabi A, Giannarelli D, Cantelmi T: Cognitive rehabilitation training in patients with brain tumor-related epilepsy and cognitive deficits: a pilot study. J Neurooncol 2015;125:419-426.
  13. Yoshioka H: Rehabilitation for the terminal cancer patient. Am J Phys Med Rehabil 1994;73:199-206.
  14. Formica V, Del Monte G, Giacchetti I, Grenga I, Giaquinto S, Fini M, Roselli M: Rehabilitation in neuro-oncology: a meta-analysis of published data and a mono-institutional experience. Integr Cancer Ther 2011;10:119-126.
  15. Jones LW, Guill B, Keir ST, Carter B S K, Friedman HS, Bigner DD, Reardon DA: Patterns of exercise across the cancer trajectory in brain tumor patients. Cancer 2006;106:2224-2232.
  16. Ewertz M, Jensen AB: Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol 2011;50:187-193.
  17. Meyers CA, Hess KR: Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression. Neuro Oncol 2003;5:89-95.
  18. Miao Y, Qiu Y, Lin Y, Lu X: Assessment of self-reported and health-related quality of life in patients with brain tumours using a modified questionnaire. J Int Med Res 2008;36:1279-1286.
  19. Shaw EG, Robbins ME: The management of radiation-induced brain injury. Cancer Treat Res 2006;128:7-22.
  20. Molassiotis A, Wilson B, Brunton L, Chaudhary H, Gattamaneni R, McBain C: Symptom experience in patients with primary brain tumours: a longitudinal exploratory study. Eur J Oncol Nurs 2010;14:410-416.
  21. Cairncross JG, Kim JH, Posner JB: Radiation therapy for brain metastases. Ann Neurol 1980;7:529-541.
  22. Posner JB: Neurologic Complications of Cancer. Philadelphia, FA Davis, 1995.
  23. Georgiou A, Grigsby PW, Perez CA: Radiation induced lumbosacral plexopathy in gynecologic tumors: clinical findings and dosimetric analysis. Int J Radiat Oncol Biol Phys 1993;26:479-482.
  24. Graus F, Slatkin NE: Papilledema in the metastatic jugular foramen syndrome. Arch Neurol 1983;40:816-818.
  25. Berger PS, Bataini JP: Radiation-induced cranial nerve palsy. Cancer 1977;40:152-155.
  26. Henson JW, Posner JB: Neurological complications; in Holland JF, Frei EI, Bast RC, Morton DL (eds): Cancer Medicine, ed 3. Philadelphia, Lea & Febiger, 1993, pp 2268-2286.
  27. Jiang H, Hampel H, Prvulovic D, Wallin A, Blennow K, Li R, Shen Y: Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease. Mol Neurodegener 2011;6:69.
  28. Chou SH, Feske SK, Atherton J, Konigsberg RG, De Jager PL, Du R, Ogilvy CS, Lo EH, Ning M: Early elevation of serum tumor necrosis factor-α is associated with poor outcome in subarachnoid hemorrhage. J Investig Med 2012;60:1054-1058.
  29. Bains JS, Oliet SH: Glia: they make your memories stick! Trends Neurosci 2007;30:417-424.
  30. Tobinick E: Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases. CNS Drugs 2011;25:145-155.
  31. Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Ha BK, Von Zastrow M, Beattie MS, Malenka RC: Control of synaptic strength by glial TNFα. Science 2002;295:2282-2285.
  32. Clark IA: How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev 2007;18:335-343.
  33. Rozen T, Swidan SZ: Elevation of CSF tumor necrosis factor alpha levels in new daily persistent headache and treatment refractory chronic migraine. Headache 2007;47:1050-1055.
  34. Aouizerat BE, Dodd M, Lee K, West C, Paul SM, Cooper BA, Wara W, Swift P, Dunn LB, Miaskowski C: Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue. Biol Res Nurs 2009;11:27-41.
  35. Tobinick E, Kim NM, Reyzin G, Rodriguez-Romanacce H, DePuy V: Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept. CNS Drugs 2012;26:1051-1070.
  36. Tobinick E: Perispinal etanercept for neuroinflammatory disorders. Drug Discov Today 2009;14:168-177.
  37. Tobinick E: Deciphering the physiology underlying the rapid clinical effects of perispinal etanercept in Alzheimer's disease. Curr Alzheimer Res 2012;9:99-109.
  38. Morris JG, Grattan-Smith P, Panegyres PK, O'Neill P, Soo YS, Langlands AO: Delayed cerebral radiation necrosis. Q J Med 1994;87:119-129.
  39. Brecher ML, Berger P, Freeman AI, Krischer J, Boyett J, Glicksman AS, Foreman E, Harris M, Jones B, Cohen ME, Duffner PK, Rowland JH, Huang YP, Batnitzky S: Computerized tomography scan findings in children with acute lymphocytic leukemia treated with three different methods of central nervous system prophylaxis. Cancer 1985;56:2430-2433.
  40. Klein M, Heimans JJ, Aaronson NK, van der Ploeg HM, Grit J, Muller M, Postma TJ, Mooij JJ, Boerman RH, Beute GN, Ossenkoppele GJ, van Imhoff GW, Dekker AW, Jolles J, Slotman BJ, Struikmans H, Taphoorn MJ: Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 2002;360:1361-1368.
  41. Meyers CA, Brown PD: Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol 2006;24:1305-1309.
  42. Kirsch NL, Levine SP, Lajiness-O'Neill R, Schnyder M: Computer-assisted interactive task guidance: facilitating the performance of a simulated vocational task. J Head Trauma Rehabil 1992;7(3):13-25.
  43. Sohlberg MM, McLaughlin KA, Pavese A, Heidrich A, Posner MI: Evaluation of attention process training and brain injury education in persons with acquired brain injury. J Clin Exp Neuropsychol 2000;22:656-676.
  44. Cicerone KD, Dahlberg C, Malec JF, Langenbahn DM, Felicetti T, Kneipp S, Ellmo W, Kalmar K, Giacino JT, Harley JP, Laatsch L, Morse PA, Catanese J: Evidence-based cognitive rehabilitation: updated review of the literature from 1998 through 2002. Arch Phys Med Rehabil 2005;86:1681-1692.
  45. Gehring K, Aaronson N, Taphoorn M, Sitskoorn M: A description of a cognitive rehabilitation programme evaluated in brain tumour patients with mild to moderate cognitive deficits. Clin Rehabil 2011;25:675-692.
  46. Robertson IH, Murre JM: Rehabilitation of brain damage: brain plasticity and principles of guided recovery. Psychol Bull 1999;125:544-575.
  47. van Zomeren AH, Brouwer WH: Clinical Neuropsychology of Attention. New York, Oxford University Press, 1994.
  48. Reich M, Lesur A, Perdrizet-Chevallier C: Depression, quality of life and breast cancer: a review of the literature. Breast Cancer Res Treat 2008;110:9-17.
  49. Honig PJ, Charney EB: Children with brain tumor headaches. Distinguishing features. Am J Dis Child 1982;136:121-124.
  50. The Childhood Brain Tumor Consortium: The epidemiology of headache among children with brain tumor. Headache in children with brain tumors. J Neurooncol 1991;10:31-46.
  51. Graci G: Pathogenesis and management of cancer-related insomnia. J Support Oncol 2005;3:349-359.
  52. Stone PC, Minton O: Cancer-related fatigue. Eur J Cancer 2008;44:1097-1104.
  53. Servaes P, Verhagen C, Bleijenberg G: Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer 2002;38:27-43.
  54. Hockenberry MJ, Hinds PS, Barrera P, Bryant R, Adams-McNeill J, Hooke C, Rasco-Baggott C, Patterson-Kelly K, Gattuso JS, Manteuffel B: Three instruments to assess fatigue in children with cancer: the child, parent and staff perspectives. J Pain Symptom Manage 2003;25:319-328.
  55. Whitsett SF, Gudmundsdottir M, Davies B, McCarthy P, Friedman D: Chemotherapy-related fatigue in childhood cancer: correlates, consequences, and coping strategies. J Pediatr Oncol Nurs 2008;25:86-96.
  56. Davies B, Whitsett SF, Bruce A, McCarthy P: A typology of fatigue in children with cancer. J Pediatr Oncol Nurs 2002;19:12-21.
  57. Meeske KA, Siegel SE, Globe DR, Mack WJ, Bernstein L: Prevalence and correlates of fatigue in long-term survivors of childhood leukemia. J Clin Oncol 2005;23:5501-5510.
  58. Amato VG, Arienta C, Sparacio F: Dorsally exophytic brain stem tumors: total removal of a medullary pilocytic astrocytoma in child. Clinicopathological considerations and case report. J Neurosurg Sci 1999;43:299-304.
  59. Lehman RA, Krishnamurthy S, Berlin CM: Weight and height deficits in children with brain stem tumors. Clin Pediatr (Phila) 2002;41:315-321.
  60. Guptill WE, Carr DB: Cancer pain assessment and management: a survey. J Back Musculoskelet Rehabil 1999;12:89-99.
  61. Von Roenn JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ: Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med 1993;119:121-126.
  62. Myers C, Stuber ML, Bonamer-Rheingans JI, Zeltzer LK: Complementary therapies and childhood cancer. Cancer Control 2005;12:172-180.
  63. Molassiotis A, Cubbin D: “Thinking outside the box”: complementary and alternative therapies use in paediatric oncology patients. Eur J Oncol Nurs 2004;8:50-60.
  64. Beider S, Moyer CA: Randomized controlled trials of pediatric massage: a review. Evid Based Complement Alternat Med 2007;4:23-34.
  65. Hernandez-Reif M, Field T, Ironson G, Beutler J, Vera Y, Hurley J, Fletcher MA, Schanberg S, Kuhn C, Fraser M: Natural killer cells and lymphocytes increase in women with breast cancer following massage therapy. Int J Neurosci 2005;115:495-510.
  66. Phipps S, Dunavant M, Gray E, Rai SN: Massage therapy in children undergoing hematopoietic stem cell transplant: results of a pilot trial. J Cancer Integr Med 2005;3:62-70.
  67. Jones LW, Friedman AH, West MJ, Mabe SK, Fraser J, Kraus WE, Friedman HS, Tresch MI, Major N, Reardon DA: Quantitative assessment of cardiorespiratory fitness, skeletal muscle function, and body composition in adults with primary malignant glioma. Cancer 2010;116:695-704.
  68. Seo TB, Kim BK, Ko IG, Kim DH, Shin MS, Kim CJ, Yoon JH, Kim H: Effect of treadmill exercise on Purkinje cell loss and astrocytic reaction in the cerebellum after traumatic brain injury. Neurosci Lett 2010;481:178-182.
  69. Meeusen R: Exercise and the brain: insight in new therapeutic modalities. Ann Transplant 2005;10:49-51.
  70. Cotman CW, Berchtold NC: Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci 2002;25:295-301.
  71. Dey S, Singh RH, Dey PK: Exercise training: significance of regional alterations in serotonin metabolism of rat brain in relation to antidepressant effect of exercise. Physiol Behav 1992;52:1095-1099.
  72. Student Contributor: The biology behind “rolling:” trends, effects and consequences of MDMA use. Serendip Studio: A Digital Ecosystem, Fueled by Serendipity. http://serendip.brynmawr.edu/biology/b103/f02/web1/student.html (accessed October 14, 2015).
  73. Report: brain tumor survivors shouldn't take it easy. Medical Breakthroughs Reported by Ivanhoe. http://www.ivanhoe.com/channels/p_channelstory.cfm?​storyid=22605 . Reported: October 19, 2009 (accessed October 14, 2015).
  74. Hoffman M: Exercise for cancer patients: fitness after treatment. Web MD. http://www.webmd.com/cancer/features/exercise-cancer-patients (accessed October 14, 2015).
  75. Alexander F: Psychosomatic Medicine: Its Principles and Applications. New York, W.W. Norton & Company, 1950.
  76. Ammon G: Psychoanalysis and Psychosomatics. New York, Springer Publishing Co., 1979.
  77. Beck AT, Rush AJ, Shaw BF, Emery G: Cognitive Therapy of Depression. New York, Guilford Press, 1979.
  78. Biktimirov TZ, Modnikov OP (eds): [Problems of Medical Psychology in Oncology and Psychosomatic Medicine]. Ulyanovsk, SVNC, 1998 (in Russian).
  79. Volkova O, Chernov M: Psychological aspects of rehabilitation for patients diagnosed with glioma; in Loginova IO (ed): [Psychological health of a person: life resource and life potential]. Krasnoyarsk, Verso, 2014, pp 46-52.
  80. Seligman ME: Authentic Happiness: Using the New Positive Psychology to Realize Your Potential for Lasting Fulfillment. New York, Free Press, 2002.
  81. Malkina-Pyh IG: [Psychology of Victim Behavior: Handbook of Practical Psychologist]. Moscow, Eksmo, 2006 (in Russian).
  82. Zalevskii GV: [Personality and Fixed Forms of Behavior]. Moscow, IP RAN, 2007 (in Russian).
  83. Seligman ME: What You Can Change and What You Can't: The Complete Guide to Successful Self-Improvement. New York, Knopf, 1993.

Article / Publication Details

First-Page Preview
Abstract of  

Published online: January 25, 2018
Cover Date: 2018

Number of Print Pages: 19
Number of Figures: 0
Number of Tables: 0

ISBN: 978-3-318-06058-4 (Print)
eISBN: 978-3-318-06059-1 (Online)

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Article Tools
Article Details

Table of Contents

Article

Recommend This
TOP